| In vitro anticancer activity evaluation of new cationic platinum (II) complexes based on imidazole moiety I Rimoldi, G Facchetti, G Lucchini, E Castiglioni, S Marchianò, N Ferri Bioorganic & medicinal chemistry 25 (6), 1907-1913, 2017 | 41 | 2017 |
| Dystrophin cardiomyopathies: clinical management, molecular pathogenesis and evolution towards precision medicine D D’Amario, A Gowran, F Canonico, E Castiglioni, D Rovina, R Santoro, ... Journal of clinical medicine 7 (9), 291, 2018 | 36 | 2018 |
| Fibrosis rescue improves cardiac function in dystrophin-deficient mice and Duchenne patient–specific cardiomyocytes by immunoproteasome modulation A Farini, A Gowran, P Bella, C Sitzia, A Scopece, E Castiglioni, D Rovina, ... The American journal of pathology 189 (2), 339-353, 2019 | 35 | 2019 |
| The endocannabinoid system and cannabidiol: Past, present, and prospective for cardiovascular diseases M Rabino, S Mallia, E Castiglioni, D Rovina, G Pompilio, A Gowran Pharmaceuticals 14 (9), 936, 2021 | 22 | 2021 |
| Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3,∆ 49,∆ 50) G Spaltro, V Vigorelli, F Casalnuovo, P Spinelli, E Castiglioni, D Rovina, ... Stem Cell Research 25, 128-131, 2017 | 10 | 2017 |
| Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c. 4435G> T, p.(Gly1479*) and c. 3474G> A, p … V Alari, S Russo, D Rovina, M Garzo, M Crippa, L Calzari, C Scalera, ... Stem Cell Research 40, 101553, 2019 | 8 | 2019 |
| Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9∆ 45-55) A Gowran, G Spaltro, F Casalnuovo, V Vigorelli, P Spinelli, E Castiglioni, ... Stem Cell Research 28, 21-24, 2018 | 8 | 2018 |
| Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51–53 of the dystrophin gene (CCMi003-A) D Rovina, E Castiglioni, A Farini, M Bellichi, C Gervasini, S Paganini, ... Stem Cell Research 40, 101544, 2019 | 6 | 2019 |
| “Betwixt Mine Eye and Heart a League Is Took”: the progress of induced pluripotent stem-cell-based models of dystrophin-associated cardiomyopathy D Rovina, E Castiglioni, F Niro, S Mallia, G Pompilio, A Gowran International journal of molecular sciences 21 (19), 6997, 2020 | 5 | 2020 |
| Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45–50 into an induced pluripotent stem cell line (CCMi005-A) D Rovina, E Castiglioni, S Mallia, M Rabino, A Farini, M Belicchi, ... Stem Cell Research 64, 102889, 2022 | 4 | 2022 |
| Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c. 1705-8 T> C. D Rovina, E Castiglioni, F Niro, A Farini, M Belicchi, E Di Fede, ... Stem Cell Research 45, 101819, 2020 | 3 | 2020 |
| APPLICATION OF THE'UPSIDE DOWN'CHIP TO MODEL CARDIOMYOPATHY ASSOCIATED WITH DUCHENNE'S MUSCULAR DYSTROPHY A Gowran, S Piazza, R Visone, E Castiglioni, G Pompilio, A Redaelli, ... TISSUE ENGINEERING PART A 28, S391-S392, 2022 | | 2022 |
| Lab resource: Stem Cell Line Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c. 1705-8 T> C. D Rovina, E Castiglioni, F Niro, A Farini, M Belicchi, E Di Fede, ... STEM CELL RESEARCH 45, 2020 | | 2020 |
| P454 The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy A Gowran, E Castiglioni, D Rovina, F Casalnuovo, P Nigro, P Spinelli, ... Cardiovascular Research 114 (suppl_1), S109-S109, 2018 | | 2018 |
